Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

licensing opportunity oncology new class

Popular

Description

I have two promising novel classes of anticancer drugs with first in class attributes available for in licensing.

The Non Proteolytic Proteasome Inhibitor demonstrated a Proteasome inhibition through a novel mechanism/target. This compound is currently at the lead generation stage.

POC : In-vitro cytotoxicactivity on human cancer cells

A screening platform could be discussed as well

Please contact

Jean-Charles Brosse

e-mail :

jcharlesbrosse@aol.com

jcharlesbrosse@gmail.com

mobile : +33607832134 

 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 676

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

Start-up pharmaceutical company from South...
175 Views
Member of Farmavita.net is looking to...
288 Views
I want to give process knowhow and NON GMO...
n/a
809 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
1066 Views
 Company portfolio: Manufacturing over 100...
1417 Views
Objective: To enter into EU domain procuring...
1195 Views
Objective: To enter into EU domain grabbing a...
949 Views